Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tracking the pipeline: immunoinformatics and the COVID-19 vaccine design
Shokouh Rezaei, Yahya Sefidbakht, Vuk Uskoković
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 18

Showing 18 citing articles:

SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
Chiranjib Chakraborty, Manojit Bhattacharya, Kuldeep Dhama
Vaccines (2023) Vol. 11, Iss. 3, pp. 682-682
Open Access | Times Cited: 66
An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 49
A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, et al.
Informatics in Medicine Unlocked (2022) Vol. 28, pp. 100862-100862
Open Access | Times Cited: 55
Advancing vaccine development in genomic era: A paradigm shift in vaccine discovery
Miraj Ud din, Xiaohui Liu, Hui Jiang, et al.
Progress in Biomedical Engineering (2025) Vol. 7, Iss. 2, pp. 022004-022004
Closed Access | Times Cited: 1
Biophysics of SARS-CoV-2 spike protein’s receptor-binding domain interaction with ACE2 and neutralizing antibodies: from computation to functional insights
Fernando Luís Barroso da Silva, Karen Paco, Aatto Laaksonen, et al.
Biophysical Reviews (2025)
Closed Access | Times Cited: 1
Organoid and microfluidics-based platforms for drug screening in COVID-19
Roya Ramezankhani, Roya Solhi, Yoke Chin Chai, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 4, pp. 1062-1076
Open Access | Times Cited: 34
Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics
Vuk Uskoković
Advances in Colloid and Interface Science (2023) Vol. 315, pp. 102903-102903
Open Access | Times Cited: 15
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates
Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 316-334
Closed Access | Times Cited: 14
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Application of in-silico approaches in subunit vaccines: Overcoming the challenges of antigen and adjuvant development
Xue Tang, Jiayin Deng, Chun‐Ting He, et al.
Journal of Controlled Release (2025), pp. 113629-113629
Closed Access
Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant
Fatemeh Bayani, Negin Safaei Hashkavaei, Vladimir N. Uversky, et al.
Computers in Biology and Medicine (2022) Vol. 147, pp. 105735-105735
Open Access | Times Cited: 15
Protective Efficacy of Multiple Epitope-Based Vaccine against Hyalomma anatolicum, Vector of Theileria annulata and Crimean–Congo Hemorrhagic Fever Virus
Abhijit Nandi, Manisha, Vandana Solanki, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 881-881
Open Access | Times Cited: 8
In silico design of a multi-epitope vaccine against the spike and the nucleocapsid proteins of the Omicron variant of SARS-CoV-2
Fatemeh Bayani, Negin Safaei Hashkavaei, Mohammad Reza Karamian, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11748-11762
Closed Access | Times Cited: 6
Exploration of potential inhibitors for SARS‐CoV‐2 Mpro considering its mutants via structure‐based drug design, molecular docking, MD simulations, MM/PBSA, and DFT calculations
Abdulrahman Ghasemlou, Vuk Uskoković, Yahya Sefidbakht
Biotechnology and Applied Biochemistry (2022) Vol. 70, Iss. 1, pp. 439-457
Closed Access | Times Cited: 9
Vaccine development strategies and impact
Arijit Nandi, Yadu Nandan Dey, Debalina Maity, et al.
Elsevier eBooks (2024), pp. 149-180
Closed Access | Times Cited: 1
T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
Iole Macchia, Valentina La Sorsa, Alessandra Ciervo, et al.
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1217-1217
Open Access | Times Cited: 1
Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332
Yanru Zhou, Weiwei Wang, Pei Zeng, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 657, pp. 16-23
Open Access | Times Cited: 3
Teaching Medical Devices through Interactive Innovation: Challenges and Rewards
Vuk Uskoković
Teaching and Learning in Medicine (2024), pp. 1-10
Closed Access
Page 1

Scroll to top